SPC
BIO icon

Stewart & Patten Company’s Bio-Rad Laboratories Class A BIO Stock Holding History

Stewart & Patten Company’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-600
Closed -$210K – 86
2020
Q1 		$210K Hold
600
– – 0.05% 82
2019
Q4 		$222K Sell
600
-1,600
-73% -$564K 0.04% 88
2019
Q3 		$732K Hold
2,200
– – 0.13% 58
2019
Q2 		$688K Hold
2,200
– – 0.12% 59
2019
Q1 		$672K Sell
2,200
-192
-8% -$51.8K 0.12% 57
2018
Q4 		$555K Sell
2,392
-8
-0.3% -$2.15K 0.11% 61
2018
Q3 		$751K Sell
2,400
-68
-3% -$21.1K 0.14% 57
2018
Q2 		$712K Hold
2,468
– – 0.14% 59
2018
Q1 		$617K Sell
2,468
-200
-7% -$50.9K 0.12% 58
2017
Q4 		$637K Hold
2,668
– – 0.11% 61
2017
Q3 		$593K Sell
2,668
-10
-0.4% -$2.25K 0.11% 59
2017
Q2 		$606K Sell
2,678
-200
-7% -$43.6K 0.11% 60
2017
Q1 		$574K Hold
2,878
– – 0.11% 58
2016
Q4 		$525K Hold
2,878
– – 0.1% 60
2016
Q3 		$471K Hold
2,878
– – 0.09% 65
2016
Q2 		$412K Hold
2,878
– – 0.08% 66
2016
Q1 		$393K Hold
2,878
– – 0.08% 68
2015
Q4 		$399K Hold
2,878
– – 0.08% 65
2015
Q3 		$387K Hold
2,878
– – 0.09% 66
2015
Q2 		$433K Hold
2,878
– – 0.09% 66
2015
Q1 		$389K Hold
2,878
– – 0.08% 70
2014
Q4 		$347K Sell
2,878
-22
-0.8% -$2.53K 0.07% 75
2014
Q3 		$329K Sell
2,900
-192
-6% -$22.8K 0.07% 74
2014
Q2 		$370K Hold
3,092
– – 0.07% 70
2014
Q1 		$396K Hold
3,092
– – 0.08% 69
2013
Q4 		$382K Hold
3,092
– – 0.08% 70
2013
Q3 		$363K Hold
3,092
– – 0.08% 71
2013
Q2 		$347K Buy
+3,092
New +$363K 0.07% 72

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Stewart & Patten Company's BIO Position: Q2 2020 in Review

Stewart & Patten Company sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2020, closing a stake of 600 shares — an estimated $210K sold.

Stewart & Patten Company first reported a position in BIO in Q2 2013 and held it in 28 quarters. The position peaked at $751K in Q3 2018. 470 funds tracked by Wall St. Rank hold BIO as of Q2 2020.

  • Stewart & Patten Company reported no remaining Bio-Rad Laboratories Class A position as of Q2 2020 after selling out during the quarter.
  • Stewart & Patten Company sold 600 Bio-Rad Laboratories Class A shares in Q2 2020, an estimated $210K.
  • Stewart & Patten Company first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 28 quarters.
  • Stewart & Patten Company's Bio-Rad Laboratories Class A position peaked at $751K in Q3 2018.
  • 470 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2020.

Based on Stewart & Patten Company's 13F filing for Q2 2020, filed 17 Jul 2020.